Kenneth M. Bahrt

2018 - Outlook Therapeutics

In 2018, Kenneth M. Bahrt earned a total compensation of $429.1K as Former Chief Medical Officer at Outlook Therapeutics, a 32% decrease compared to previous year.

Compensation breakdown

Salary$400,000
Other$29,082
Total$429,082

Bahrt received $400K in salary, accounting for 93% of the total pay in 2018.

Bahrt also received $29.1K in other compensation.

Rankings

In 2018, Kenneth M. Bahrt's compensation ranked 12,347th out of 14,244 executives tracked by ExecPay. In other words, Bahrt earned more than 13.3% of executives.

ClassificationRankingPercentile
All
12,347
out of 14,244
13th
Division
Manufacturing
4,998
out of 5,765
13th
Major group
Chemicals And Allied Products
1,890
out of 2,128
11th
Industry group
Drugs
1,618
out of 1,817
11th
Industry
Biological Products, Except Diagnostic Substances
312
out of 339
8th
Source: SEC filing on August 1, 2019.

Bahrt's colleagues

We found three more compensation records of executives who worked with Kenneth M. Bahrt at Outlook Therapeutics in 2018.

2018

Pankaj Mohan

Outlook Therapeutics

Chief Executive Officer

2018

Lawrence Kenyon

Outlook Therapeutics

Chief Executive Officer

2018

Stephen McAndrew

Outlook Therapeutics

Former Senior Vice President, Business Strategy & Development

News

You may also like